Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.57% | 13.97% | 19.60% | 19.37% | 9.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.57% | 13.97% | 19.60% | 19.37% | 9.78% |
| Cost of Revenue | 30.70% | 31.16% | 20.37% | 20.14% | -15.53% |
| Gross Profit | 10.38% | 10.76% | 19.43% | 19.21% | 16.28% |
| SG&A Expenses | 15.20% | 15.60% | 24.21% | 23.98% | -5.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 71.04% | 70.93% | 54.13% | 54.20% | 55.45% |
| Total Operating Expenses | 14.57% | 14.97% | 26.72% | 26.48% | -1.82% |
| Operating Income | 10.77% | 11.16% | -18.40% | -18.55% | 64.32% |
| Income Before Tax | 10.12% | 10.50% | -39.31% | -39.42% | 65.32% |
| Income Tax Expenses | -35.14% | -34.92% | 313.35% | 312.61% | 4.48% |
| Earnings from Continuing Operations | 12.92% | 13.31% | -50.85% | -50.94% | 71.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.92% | 13.31% | -50.85% | -50.94% | 71.49% |
| EBIT | 10.77% | 11.16% | -18.40% | -18.55% | 64.32% |
| EBITDA | 10.96% | 11.35% | -21.09% | -21.24% | 63.73% |
| EPS Basic | 14.29% | 14.29% | -33.33% | -33.33% | 75.00% |
| Normalized Basic EPS | 0.00% | 0.00% | -50.00% | -50.00% | 66.67% |
| EPS Diluted | 14.29% | 14.29% | -33.33% | -33.33% | 75.00% |
| Normalized Diluted EPS | 0.00% | 0.00% | -50.00% | -50.00% | 66.67% |
| Average Basic Shares Outstanding | -3.12% | -3.12% | -3.90% | -3.90% | -3.16% |
| Average Diluted Shares Outstanding | -3.12% | -3.12% | -3.90% | -3.90% | -3.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |